Join Dr Jorg Taubel at the 2015 Annual Meeting of the ACCP (American College of Clinical Pharmacology) for his latest scientific poster presentations on cost saving strategies for early phase drug development.Sunday, 27 September, 17h30 to 19h30 - Abstract Poster Board Number 55Confirmation of the Cardiac Safety of Rupatadine in a SAD and MAD study in Japanese healthy subjects using intensive ECG assessmentsMonday, 28 September, 17h30 to 19h30 - Abstract Poster Board Number 66Pharmacokinetics, safety and tolerability of Rupatadine in healthy Japanese volunteersA global audience will come together for presentations from an international Faculty of over 75 speakers in three Pre-meeting Workshops and 12 Symposia on a series of topics ranging from research and drug development to patient care.

Latest news

Recruiting breastfeeding mothers into clinical trials through transparent and sensitive conversations

April 30, 2024
Richmond Pharmacology's study on merotocin showed low transfer to breast milk, overcoming recruitment challenges through proximity to a maternity ward.
Read more

Announcement of Jorg Becoming President Elect

April 22, 2024
Richmond Pharmacology announces CEO Dr. Jorg Taubel's appointment as President Elect of Germany's AGAH, where he will enhance early-phase clinical research over a six-year term.
Read more

Events

AHA Hypertension Scientific Sessions 2024

5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event